Jeremy Force
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 29
- Cancer Immunotherapy and Biomarkers 11
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 5
-
- Advanced Breast Cancer Therapies 9
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Judah Folkman (4 shared papers)John V. Heymach (4 shared papers)Zachary C. Hartman (2 shared papers)Li-Chung Tsao (1 shared paper)Terry Hyslop (10 shared papers)Paul Beaudry (2 shared papers)Laura H. Rosenberger (8 shared papers)Rachel A. Greenup (8 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Cancer Research (8 papers)Clinical Cancer Research (5 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Annals of Surgical Oncology (3 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Jeremy Force
45 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 588
- Oncology 616
- Pathology and Forensic Medicine 215
- Molecular Biology 653
- Pulmonary and Respiratory Medicine 273
Countries citing papers authored by Jeremy Force
This map shows the geographic impact of Jeremy Force's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Force with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Force more than expected).
Fields of papers citing papers by Jeremy Force
This network shows the impact of papers produced by Jeremy Force. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Force. The network helps show where Jeremy Force may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeremy Force, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 162 | |
| 2 | 2018 | 147 | |
| 3 | 2005 | 132 | |
| 4 | 2021 | 128 | |
| 5 | 2005 | 109 | |
| 6 | Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. | 2003 | 91 |
| 7 | 2018 | 75 | |
| 8 | 2008 | 70 | |
| 9 | 2011 | 58 | |
| 10 | 2020 | 45 | |
| 11 | 2019 | 43 | |
| 12 | 2021 | 31 | |
| 13 | 2023 | 29 | |
| 14 | 2021 | 28 | |
| 15 | 2017 | 28 | |
| 16 | 2014 | 27 | |
| 17 | 2018 | 24 | |
| 18 | 2018 | 22 | |
| 19 | 2020 | 21 | |
| 20 | 2011 | 15 |
About Jeremy Force
Jeremy Force is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cancer Immunotherapy and Biomarkers (11 papers), Advanced Breast Cancer Therapies (9 papers), HER2/EGFR in Cancer Research (8 papers), Lung Cancer Treatments and Mutations (6 papers), Breast Lesions and Carcinomas (6 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Cancer Research (588 citations), Oncology (616 citations), Pathology and Forensic Medicine (215 citations), Molecular Biology (653 citations) and Pulmonary and Respiratory Medicine (273 citations). Jeremy Force has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Judah Folkman, John V. Heymach, Zachary C. Hartman, Li-Chung Tsao, Terry Hyslop, Paul Beaudry, Laura H. Rosenberger, Rachel A. Greenup, Jennifer K. Plichta and Oluwadamilola M. Fayanju. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.